| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | Daniel C Brennan | |
| Siddiq Anwar | |||
| P2860 | cites work | 1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells | Q42375929 |
| Assessment of Efficacy and Safety of FK778 in Comparison With Standard Care in Renal Transplant Recipients With Untreated BK Nephropathy | Q42673998 | ||
| A prospective longitudinal study of BK virus infection in 104 renal transplant recipients | Q43603996 | ||
| Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction | Q45262232 | ||
| Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. | Q45265773 | ||
| Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year | Q45354366 | ||
| Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients | Q45370223 | ||
| Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection | Q47965842 | ||
| Ureteral stent placement and BK viremia in kidney transplant recipients. | Q54275086 | ||
| Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation | Q24627138 | ||
| BK virus infection in transplant recipients: an overview and update | Q36505713 | ||
| Antivirals for the treatment of polyomavirus BK replication | Q36723806 | ||
| Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial. | Q36952467 | ||
| The decade of polyomavirus BK-associated nephropathy: state of affairs | Q37417381 | ||
| Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial | Q37621540 | ||
| BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results | Q37670279 | ||
| Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. | Q40132770 | ||
| CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation | Q42246598 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 445-447 | |
| P577 | publication date | 2014-01-30 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn? | |
| P478 | volume | 9 |
| Q104472864 | Advances in BK Virus Complications in Organ Transplantation and Beyond |
| Q37375153 | BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches |
| Q38323818 | Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. |
| Q94570749 | Pathogenicity of BK virus on the urinary system |
Search more.